With the Pfizer (PFE)/BioNTech (BNTX) booster guidance in the rearview mirror, the CDC and the country’s other regulatory and public health agencies are gearing up to tackle Moderna’s (MRNA) and eventually Johnson & Johnson’s (JNJ) booster filings for recipients of those vaccines.
Meanwhile, many have wondered why the U.S. is not following Europe’s and Canada’s lead in allowing mixing and matching of vaccine brands in order to be considered fully vaccinated or for booster doses.
CDC Director Dr. Rochelle Walensky told that information is not too far away.
“We’re starting to see some of the mix-and-match data,” she said, noting that studies are already underway.
“As soon as we have those data to present, both to the FDA and to the CDC, we’ll have recommendations there as well,” Walensky said.
Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases (NIAID), said Tuesday the first batch of data pertains to Moderna as a booster for either the J&J or Pfizer vaccines.
That data is available now, and data from trials of the other two vaccines as mixed boosters are forthcoming in the next month.
Source: Yahoo Finance
Association between COVID-19 outcomes and mask mandates, adherence, and attitudes
Using an event study design, authors estimate the treatment effect of the introduction of mask mandates (shown on the vertical red line) on Z-scored population-normalized COVID-19 daily new confirmed cases, daily new hospitalization admissions proportion, and deaths across all 50 states and D.C. over the time period between February 1 and September 27, 2020.
Source: Dhaval Adjodah, Karthik Dinakar, Matteo Chinazzi, Samuel P. Fraiberger, Alex Pentland, Samantha Bates, Kyle Staller, Alex Vespignani, Deepak L. Bhatt. Association between COVID-19 Outcomes and Mask Mandates, Adherence, and Attitudes.